Skip to main content
OpenTrials
Completed

NCT Number: NCT07101224

Data Registry in Chinese Hemophilia A and B Patients

This is an open-label, prospective, multi-center, patient registry in Chinese Hemophilia A and B patients treated with anti-hemophilic coagulation factor replacement therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemophilia A Blood Coagulation Disorders Blood Coagulation Disorders, Inherited Coagulation Protein Disorders Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Genetic Diseases, X-Linked Hematologic Diseases Hemic and Lymphatic Diseases Hemophilia B Hemorrhagic Disorders

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital of Blood disease

Tianjin, Tianjin Municipality, 300020, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

：

Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the study:

  • Hemophilia A and Hemophilia B patient diagnosed;
  • Taking anti-hemophilic coagulation factor replacement therapy during the 2 year registry period.

Exclusion criteria

  • Unwilling or unable to follow the terms of the protocol.

Treatment and study plan

Primary outcomes

  1. The incidence of MIEs and other SAEs

    Time frame: at the end of 2 year data registry

    The incidence of MIE(medically important events)s and other SAE(serious adverse event)s in the anti-hemophilic replacement treatment

Secondary outcomes

  1. Treatment regimen

    Time frame: at the end of 2 year data registry

    Treatment regimen of anti-hemophilic replacement treatment

Sponsors and collaborators

Lead sponsor

Institute of Hematology & Blood Diseases Hospital, China

Other

Registry information

Official study title

Data Registry in Chinese Hemophilia A and B Patients Related to the Use of Anti-hemophilic Coagulation Factor Replacement Therapy

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Aug 3, 2025
Registry last updated
Aug 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.